Accord BioPharma get FDA OK for Herceptin biosimilar
Hercessi is used fora variety of cancer treatments.
Source: drugstorenews.com
Binish Chudgar News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Binish Chudgar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Binish Chudgar Today - Breaking & Trending Today
Herceptin Biosimilar, Hercessi, Approved by FDA in Breast, Gastric Cancers
The FDA has approved Hercessi for the adjuvant treatment of HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Source: curetoday.com
FDA Approves Trastuzumab-strf for HER2-Overexpressing Breast and Gastric/GEJ Cancer
The FDA has approved trastuzumab-strf for HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or GEJ adenocarcinoma.
Source: onclive.com
Intas in pact with Spanish drug maker mAbxience to sell biosimilar etanercept in over 150 countries
MAbxience, a majority-owned company of German drug maker Fresenius Kabi, also has partial ownership from Insud Pharma, will be responsible for the development, manufacturing, and supply of the Etanercept biosimilar.
Source: indiatimes.com
Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India
/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with Intas Pharmaceuticals Limited ("Intas") for the...
Source: prnewswire.com